DENVER -- Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had ...

Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease. Although late-stage kidney cancer generated ...

Patients with kidney cancer brain metastases have a poor prognosis and have been excluded from most clinical trials of ...

Results from the phase II LenCabo trial show that lenvatinib plus everolimus significantly prolonged progression-free ...

Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.

D ENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed a high-fiber diet, a small prospective study showed.

A large two-cohort analysis published in BMC Nephrology has found that patients with autosomal dominant polycystic kidney ...

Patients with urinary stones show poorer survival in upper tract urothelial carcinoma. Find out how stone history may affect ...

Cancer survival rates have improved over three decades as cancer mortality rates decline, according to new data published today by the Australian Institute of Health and Welfare (AIHW). The report, ...